Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
Nuvectis Pharma (NVCT) Stock Price & Analysis
35 Followers
NVCT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.21 - $17.82
Previous Close$17.54
Volume9.11K
Average Volume (3M)31.01K
Market Cap
$281.41M
Enterprise Value$265.27M
Total Cash (Recent Filing)$15.50M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-12.3
Beta0.07
Next Earnings
Aug 04, 2023EPS Estimate
-$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.43
Shares Outstanding16,007,425
10 Day Avg. Volume49,632
30 Day Avg. Volume31,006
Standard Deviation0.22
R-Squared0.01
Alpha0.08
Financial Highlights & Ratios
Price to Book (P/B)22.76
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-14.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit122.24
Enterprise Value/Ebitda-13.01
Forecast
1Y Price Target
$21.00Price Target Upside19.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Nuvectis Pharma News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NVCT FAQ
What was Nuvectis Pharma’s price range in the past 12 months?
Nuvectis Pharma lowest stock price was $6.21 and its highest was $17.82 in the past 12 months.
What is Nuvectis Pharma’s market cap?
Currently, no data Available
When is Nuvectis Pharma’s upcoming earnings report date?
Nuvectis Pharma’s upcoming earnings report date is Aug 04, 2023 which is in 63 days.
How were Nuvectis Pharma’s earnings last quarter?
Nuvectis Pharma released its earnings results on May 10, 2023. The company reported -$0.27 earnings per share for the quarter, beating the consensus estimate of -$0.441 by $0.171.
Is Nuvectis Pharma overvalued?
According to Wall Street analysts Nuvectis Pharma’s price is currently Undervalued.
Does Nuvectis Pharma pay dividends?
Nuvectis Pharma does not currently pay dividends.
What is Nuvectis Pharma’s EPS estimate?
Nuvectis Pharma’s EPS estimate is -$0.29.
How many shares outstanding does Nuvectis Pharma have?
Nuvectis Pharma has 16,007,425 shares outstanding.
What happened to Nuvectis Pharma’s price movement after its last earnings report?
Nuvectis Pharma reported an EPS of -$0.27 in its last earnings report, beating expectations of -$0.441. Following the earnings report the stock price went up 0.332%.
Which hedge fund is a major shareholder of Nuvectis Pharma?
Currently, no hedge funds are holding shares in NVCT
---
Nuvectis Pharma Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$21.00 (19.45% Upside)
$21.00 (19.45% Upside)
Blogger Sentiment
Bullish
NVCT Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $64.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.00%
12-Months-Change
Fundamentals
Return on Equity
-150.49%
Trailing 12-Months
Asset Growth
-8.00%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Nuvectis Pharma
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its pipeline products include NXP800, NXP900.
---
Top 5 ETFs holding NVCT
Vanguard Total Stock Market ETF
$2.68M
Up to five ETFs with an Outperform Smart Score that hold NVCT. The ETFs are listed according to market value of NVCT within the ETF
---
Acer Therapeutics
―
Aptose Biosciences
―
Actinium Pharmaceuticals
―
Bio-Path Holdings
―
---